These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5374678)

  • 1. [Contribution to the study of synthetic progestinics. Analysis of a 17-hydroxyprogesterone derivative combined with ethinyl-estradiol].
    Peano M; Agnese M; Yammaki Y; Araujo Peano N; Groisman M; Canedo A; Correa A; Villano G; Cardoso A
    Minerva Ginecol; 1969 Dec; 21(24):1667-94. PubMed ID: 5374678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new 2-step combination preparation for hormonal contraception].
    James A
    Schweiz Rundsch Med Prax; 1982 Dec; 71(51):1990-3. PubMed ID: 7163134
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of norethisterone acetate on the uterine mucosa].
    Robey M; Hervé R; de Brux J; Sergent P
    Gynecol Obstet (Paris); 1968; 67(4):425-36. PubMed ID: 5701976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contraceptive activity and mechanism of action of combinations of a new 17 alpha-acetoxyprogesterone derivative and ethinyl estradiol].
    Nikitina GV; Korkhov VV; Grinenko GS; Kadatskiĭ GM
    Farmakol Toksikol; 1980; 43(2):196-9. PubMed ID: 6160051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A serial method for ovulation inhibition using ethinyl estradiol].
    McBride WG
    Arzneimittelforschung; 1969 Aug; 19(8):1271-3. PubMed ID: 5820291
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of oral contraceptives on the mental state of women.
    Cepelák J; Tosovská Z; Havránek F
    Act Nerv Super (Praha); 1967 Nov; 9(4):408-9. PubMed ID: 5612955
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombocyte aggregation during hormonal treatment of dysfunctional uterine hemorrhage].
    Mel'nikova VS; Lutsik LA
    Lab Delo; 1985; (2):98-9. PubMed ID: 2581037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic study of the quingestanol-ethinyl estradiol combination].
    Eben-Moussi E; Van den Driessche J
    Rev Fr Gynecol Obstet; 1971 Apr; 66(4):283-5. PubMed ID: 5104265
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary clinical study of Wy 3707 with ethinyl estradiol as an oral contraceptive.
    O'Roark HC; Lock FR; Smith Foushee JH; Burt RL
    Int J Fertil; 1966; 11(4):405-11. PubMed ID: 5970363
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the interactions of ethynyl oestradiol and norgestrel.
    Edgren RA; Jones RC; Peterson DL; Gillen AL
    Acta Endocrinol (Copenh); 1967; 54():Suppl 115:3-21. PubMed ID: 6071573
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sequential ovariostatic therapy with ethinyl estradiol associated with 6-dehydro-retro-progesterone. Comparative study of 2 different dosages].
    Schockaert JA; De Cooman E
    Minerva Ginecol; 1968 Feb; 20(4):343-54. PubMed ID: 5738734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia.
    Acta Obstet Gynecol Scand Suppl; 1982; 111():1-60. PubMed ID: 6216716
    [No Abstract]   [Full Text] [Related]  

  • 16. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norethisterone acetate and ethinylestradiol in early human pregnancy.
    Pulkkinen MO; Düsterberg B; Hasan H; Kivikoski A; Laajoki V
    Teratology; 1984 Apr; 29(2):241-9. PubMed ID: 6429876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive].
    Vekemans M
    Rev Med Brux; 1984 Jan; 5(1):13-9. PubMed ID: 6701404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.